Dozens Of New Cancer Drugs Do Little To Improve Survival, Frustrating Patients
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
The independent source for health policy research, polling, and news.
7,941 - 7,960 of 15,454 Results
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
Republicans’ delay in finding common ground to repeal and replace the health law raises risks that coverage could shrink and rates rise even more, the industry says.
New advocacy groups like Indivisible California weigh strategies for long-haul political activism, including protests.
The first overhaul of federal regulations in almost 30 years for home health care agencies will require them to be much more responsive to what aging patients and their caregivers need or want.
In an interview with Kaiser Health News, Michael Botticelli outlines his concerns about how GOP efforts to dismantle the health law’s coverage expansions could jeopardize treatment for people in need.
Remarks by Sen. Mike Lee and Reps. Jim Jordan and Mark Meadows reflect growing uncertainty about Republicans’ path to overhaul Obamacare.
Insurers and care providers say efforts to fix how consumers are notified also raise concerns.
Prescription pain pills are strong sellers in this southeastern Kentucky region that’s long struggled with high rates of joblessness and poor health.
A Harvard health policy expert faced a racing heartbeat and $6,000 deductible on his insurance plan. What did he do?
With federal investigators bearing down on his committee, Rep. Tom Price, R-Ga., who is line to be secretary of the Department of Health and Human Services, showed little restraint in investing in health companies.
Kaiser Health News reporter Shefali Luthra discusses the controversy surrounding Kaleo, a company that makes a life-saving auto-injector for opioid drug overdoses on Weekend Edition.
The state passed a bailout to make ACA plans more affordable, defeated a plan to offer bare bones insurance and is floating a state-sponsored public option.
People who think the change in administrations may save them from having to pay a fine for not having insurance in 2016 could be in for a rude surprise.
Luke Whitbeck’s life was saved by a rare disease drug, but it costs $300,000 a year.
Humor may be an antidote for the pain of death for both patients and survivors.
Republicans, who don’t have the votes to repeal the ACA directly, are hoping to use this strict budget strategy that requires only a majority vote to strip the health law of provisions they oppose.
California state Sen. Ricardo Lara talks about progress and setbacks in the Trump era.
Many seniors are denied coverage because therapists mistakenly believe that they must be making improvements to qualify for coverage.
Employer medical insurance still covers more people than any other kind. A Republican replacement for Obamacare could spread instability beyond the health law’s shaky marketplace plans.
A bill recently introduced in the California legislature would require insurance companies to cover fertility-preserving services for patients at risk of infertility because of necessary medical treatments.
© 2026 KFF